Myles Minter
Stock Analyst at William Blair
(1.09)
# 2,664
Out of 4,412 analysts
16
Total ratings
46.15%
Success rate
-11.25%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPHM Reneo Pharmaceuticals | Initiates: Outperform | n/a | $1.67 | - | 1 | Nov 15, 2023 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $9.15 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $26.55 | +167.42% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $107.97 | - | 1 | Jul 24, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiates: Outperform | n/a | $397.48 | - | 1 | May 30, 2023 | |
| PRAX Praxis Precision Medicines | Downgrades: Market Perform | n/a | $54.80 | - | 2 | Mar 6, 2023 | |
| ARGX argenx SE | Initiates: Outperform | n/a | $372.80 | - | 1 | Dec 7, 2022 | |
| LRMR Larimar Therapeutics | Upgrades: Outperform | n/a | $6.44 | - | 3 | Sep 19, 2022 | |
| ALNY Alnylam Pharmaceuticals | Initiates: Outperform | n/a | $143.31 | - | 1 | Jun 7, 2022 | |
| IONS Ionis Pharmaceuticals | Upgrades: Outperform | n/a | $41.59 | - | 1 | Dec 14, 2021 | |
| ALEC Alector | Initiates: Outperform | n/a | $5.25 | - | 1 | Sep 27, 2021 | |
| TBIO Telesis Bio | Downgrades: Market Perform | n/a | $0.32 | - | 1 | Aug 3, 2021 | |
| NBIX Neurocrine Biosciences | Initiates: Outperform | n/a | $135.99 | - | 1 | Feb 24, 2020 |
Reneo Pharmaceuticals
Nov 15, 2023
Initiates: Outperform
Price Target: n/a
Current: $1.67
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $9.15
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $26.55
Upside: +167.42%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $107.97
Upside: -
Vertex Pharmaceuticals
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $397.48
Upside: -
Praxis Precision Medicines
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $54.80
Upside: -
argenx SE
Dec 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $372.80
Upside: -
Larimar Therapeutics
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $6.44
Upside: -
Alnylam Pharmaceuticals
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $143.31
Upside: -
Ionis Pharmaceuticals
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $41.59
Upside: -
Alector
Sep 27, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.25
Upside: -
Telesis Bio
Aug 3, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $0.32
Upside: -
Neurocrine Biosciences
Feb 24, 2020
Initiates: Outperform
Price Target: n/a
Current: $135.99
Upside: -